Harnessing gene repression to inhibit leukemia
- PMID: 25849269
- DOI: 10.1038/nm.3834
Harnessing gene repression to inhibit leukemia
Comment on
-
DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.Nat Med. 2015 Apr;21(4):335-43. doi: 10.1038/nm.3832. Epub 2015 Mar 30. Nat Med. 2015. PMID: 25822366 Free PMC article.
Similar articles
-
DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.Nat Med. 2015 Apr;21(4):335-43. doi: 10.1038/nm.3832. Epub 2015 Mar 30. Nat Med. 2015. PMID: 25822366 Free PMC article.
-
A role for DOT1L in MLL-rearranged leukemias.Epigenomics. 2011 Dec;3(6):667-70. doi: 10.2217/epi.11.98. Epigenomics. 2011. PMID: 22126283 No abstract available.
-
The role of DOT1L in the maintenance of leukemia gene expression.Curr Opin Genet Dev. 2016 Feb;36:68-72. doi: 10.1016/j.gde.2016.03.015. Epub 2016 May 3. Curr Opin Genet Dev. 2016. PMID: 27151433 Review.
-
Trithorax group genes in hematopoiesis.Oncotarget. 2015 Jul 20;6(20):17855-6. doi: 10.18632/oncotarget.4882. Oncotarget. 2015. PMID: 26257003 Free PMC article. No abstract available.
-
Drug discovery in rare indications: opportunities and challenges.Hematology Am Soc Hematol Educ Program. 2013;2013:19-23. doi: 10.1182/asheducation-2013.1.19. Hematology Am Soc Hematol Educ Program. 2013. PMID: 24319157 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical